NASDAQ
Shares of Travere Therapeutics, Inc. (NASDAQ: TVTX - Get Free Report) have been assigned a consensus rating of "Moderate Buy" from the seventeen ratings firms that are currently covering the company, ...
Federated Hermes Inc. cut its stake in shares of Travere Therapeutics, Inc. (NASDAQ: TVTX) by 21.6% in the second quarter, according to the company in its most recent Form 13F filing with the Securiti...
SAN DIEGO--(BUSINESS WIRE)--Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that on December 10, 2025, the Compensation Committee of its Board of Directors granted inducement equity grants t...
Franklin Resources Inc. lifted its stake in Travere Therapeutics, Inc. (NASDAQ: TVTX) by 44.8% in the second quarter, according to the company in its most recent disclosure with the Securities and Exc...
Capital Fund Management S.A. bought a new position in Travere Therapeutics, Inc. (NASDAQ: TVTX) during the second quarter, according to the company in its most recent 13F filing with the SEC. The fund...
The biotech sector began December with notable weakness, as both IBB and XBI ETFs declined over two percent during trading on Monday. The sector has bounced back since. However, small biotech stocks ...
Travere Therapeutics, Inc. (NASDAQ: TVTX - Get Free Report) reached a new 52-week high on Friday. The company traded as high as $37.50 and last traded at $36.0350, with a volume of 97887 shares. The s...
Travere Therapeutics has surged ~107% since my last 'Buy' rating, driven by FILSPARI's strong performance and approvals. TVTX's market cap has more than doubled in six months, reflecting confidence in...
New York City-based Armistice Capital sold 2,152,000 shares of Travere Therapeutics for an estimated $29.3 million in the third quarter. At quarter-end, the fund reporting holding 6.7 million shares o...
Campbell and CO Investment Adviser LLC bought a new stake in Travere Therapeutics, Inc. (NASDAQ: TVTX) during the undefined quarter, according to the company in its most recent 13F filing with the SEC...
No price data available for this timeframe.